Rational Development of Bacterial Ureases Inhibitors

被引:20
|
作者
Loharch, Saurabh [1 ]
Berlicki, Lukasz [1 ]
机构
[1] Wroclaw Univ Sci & Technol, Fac Chem, Dept Bioorgan Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland
来源
CHEMICAL RECORD | 2022年 / 22卷 / 08期
关键词
Antimicrobials; Computer-aided drug design; Ebselen; Enzyme; Phosphonates; HELICOBACTER-PYLORI UREASE; BACILLUS-PASTEURII UREASE; GASTRIC EPITHELIAL-CELLS; X-RAY DATA; NITRIFICATION INHIBITORS; EC; 3.5.1.5; PURIFICATION; INSIGHTS; AMMONIA; INACTIVATION;
D O I
10.1002/tcr.202200026
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Urease, an enzyme that catalyzes the hydrolysis of urea, is a virulence factor of various pathogenic bacteria. In particular, Helicobacter pylori, that colonizes the digestive tract and Proteus spp., that can infect the urinary tract, are related to urease activity. Therefore, urease inhibitors are considered as potential therapeutics against these infections. This review describes current knowledge of the structures, activity, and biological importance of bacterial ureases. Moreover, the structure-based design of several classes of bacterial urease inhibitors is presented and discussed. Phosphinic and phosphonic acids were applied as transition-state analogues, while Michael acceptors and ebselen derivatives were applied as covalent binders of cysteine residue. This review incorporates bacterial urease inhibitors from literature published between 2008 and 2021.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Effect of soybean ureases on seed germination and plant development
    Rechenmacher, Ciliana
    Wiebke-Strohm, Beatriz
    de Oliveira-Busatto, Luisa A.
    Polacco, Joseph C.
    Carlini, Celia R.
    Bodanese-Zanettini, Maria H.
    GENETICS AND MOLECULAR BIOLOGY, 2017, 40 (01) : 209 - 216
  • [22] Rational Development of Hbv Capsid Inhibitors Aided by Molecular Dynamics
    Korablyov, Maksym
    Pavlova, Anna
    Chipot, Christophe
    Gumbart, James C.
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 344A - 344A
  • [23] Rational Design and Development of HDAC Inhibitors for Breast Cancer Treatment
    Mody, Deepansh
    Bouckaert, Julie
    Savvides, Savvas N.
    Gupta, Vibha
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (45) : 4610 - 4629
  • [24] Rational development of histone deacetylase inhibitors as anticancer agents: A review
    Acharya, MR
    Sparreboom, A
    Venitz, J
    Figg, WD
    MOLECULAR PHARMACOLOGY, 2005, 68 (04) : 917 - 932
  • [25] Rational Development of HBV Capsid Inhibitors Aided by Molecular Dynamics
    Pavlova, Anna
    Korablyov, Maksym
    Chipot, Chris
    Gumbart, James
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 673A - 673A
  • [26] N-substituted aminomethanephosphonic and aminomethane-P-methylphosphinic acids as inhibitors of ureases
    Berlicki, Lukasz
    Bochno, Marta
    Grabowiecka, Agnieszka
    Bialas, Arkadiusz
    Kosikowska, Paulina
    Kafarski, Pawel
    AMINO ACIDS, 2012, 42 (05) : 1937 - 1945
  • [27] Efficient sodium bisulfite-catalyzed synthesis of benzothiazoles and their potential as ureases inhibitors
    Araujo, Debora Pereira
    Santos Morais, Vinicius Stefano
    de Fatima, Angelo
    Modolo, Luzia Valentina
    RSC ADVANCES, 2015, 5 (36) : 28814 - 28821
  • [28] Rational design and development of radiation-sensitizing histone deacetylase inhibitors
    Jung, M
    Kozikowski, A
    Dritschilo, A
    CHEMISTRY & BIODIVERSITY, 2005, 2 (11) : 1452 - 1461
  • [29] Rational design and development of novel NAE inhibitors for the treatment of pancreatic cancer
    Cheng Lu
    Peng Lu
    Lei Gong
    Li-Juan Zhu
    Yuanyuan An
    Yubin Wang
    Medicinal Chemistry Research, 2023, 32 : 442 - 474
  • [30] Rational design and development of novel NAE inhibitors for the treatment of pancreatic cancer
    Lu, Cheng
    Lu, Peng
    Gong, Lei
    Zhu, Li-Juan
    An, Yuanyuan
    Wang, Yubin
    MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (03) : 442 - 474